ST宁科: ST宁科2025年第三次临时股东会材料

Group 1 - The company is undergoing a pre-restructuring process, with a court decision made on May 30, 2024, to initiate pre-restructuring for Ningxia Zhongke Biological Technology Co., Ltd. and its subsidiary Ningxia Zhongke New Materials Co., Ltd. [4] - The company has identified two potential restructuring investors, with Hunan Chuntou Industrial Development Co., Ltd. being the main investor expected to gain actual control after the restructuring is completed [4][7] - The company plans to manage its related transactions more effectively and has estimated that the total amount of daily related transactions for 2025 will not exceed RMB 110 million [5] Group 2 - The expected daily related transactions include "technical consulting services" and "beneficial debt borrowing," with a total estimated amount of RMB 10 million for beneficial debt borrowing and RMB 200,000 for technical consulting services [5][9] - The company will ensure that all related transactions are conducted at fair market prices and will not harm the interests of the company or its minority shareholders [9][10] - The company maintains independence in its operations, ensuring that related transactions do not affect its independence or create dependency on related parties [10]